Is PFE a good stock to buy now? We came across a bullish thesis on Pfizer Inc. on Investomine’s Substack. In this article, we ...

Trevi Therapeutics (TRVI) advances Haduvio for IPF cough/RCC; Phase 2 IPF data strong, but funding, safety & opioid-label ...

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast a dominant position in the lucrative oncology space. Oncology or ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the randomized Phase 2 FOURLIGHT-1 study evaluating ...

I’ve always been impressed by how a few individuals with a passion for something can make big things happen. Consider what has happened in Crete, Nebraska. It was deemed that ...

Welcome to the beautiful, bracket-busting madness of 2026. For three weeks, logic goes out the window for the casuals, but for us, the chaos is where the long-term profit lives. While others are ...

Backed by exclusive insights from entertainment expert Lynn Carratt, our prediction market deep dive reveals the real Best Picture frontrunner and the titles most likely to cause an upset. Don't just ...

Looking ahead to 2030, our model projects GOOGL could trade at an average price of $488.51, with a potential range between $366.38 and $610.64. This represents a potential 59.9% return from today's ...

From Field of 68 picks to Final Four futures, we’re delivering sharp insights and "why-didn't-I-think-of-that" logic for the men's tournament. The madness is mandatory; the losses are optional.

Starting prices range from $45,000 to $58,000 — substantially lower than its full-size SUV — which could position Rivian as a ...